{"id":22778,"date":"2026-06-22T09:43:20","date_gmt":"2026-06-22T02:43:20","guid":{"rendered":"https:\/\/www.nanovest.io/blog\/?p=22778"},"modified":"2026-06-22T09:43:20","modified_gmt":"2026-06-22T02:43:20","slug":"abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee","status":"publish","type":"post","link":"https:\/\/www.nanovest.io/blog\/saham-as\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\/","title":{"rendered":"AbbVie Perkuat Bisnis Imunologi Lewat Akuisisi Apogee"},"content":{"rendered":"<p><a href=\"https:\/\/nanovest.go.link\/page=IndividualStockDetail?action=navigate&amp;is_param=true&amp;symbol=ABBV&amp;adj_t=1rhus2a1&amp;adj_deep_link=nanovest%3A%2F%2Fpage%3DIndividualStockDetail%3Faction%3Dnavigate%26is_param%3Dtrue%26symbol%3DABBV\"><span style=\"font-weight: 400;\">AbbVie (ABBV)<\/span><\/a><span style=\"font-weight: 400;\"> dikabarkan semakin dekat untuk mengakuisisi perusahaan bioteknologi Apogee Therapeutics dalam transaksi senilai sekitar US$10,9 miliar. Jika terealisasi, kesepakatan ini akan menjadi akuisisi terbesar AbbVie sejak pembelian Allergan senilai US$80 miliar pada 2019.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Menurut sejumlah laporan media internasional, investor Apogee diperkirakan akan menerima pembayaran tunai dengan premi sekitar 60% dibanding harga penutupan saham perusahaan sebelum kabar akuisisi muncul. Pengumuman resmi disebut dapat dilakukan dalam waktu dekat apabila negosiasi berjalan sesuai rencana.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Langkah ini menunjukkan upaya AbbVie untuk terus memperkuat portofolio obat imunologi, salah satu sumber pertumbuhan terpenting perusahaan setelah era dominasi Humira mulai berakhir.<\/span><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_86 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Daftar Isi <\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.nanovest.io/blog\/saham-as\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\/#Fokus_pada_Pasar_Penyakit_Inflamasi_yang_Besar\" >Fokus pada Pasar Penyakit Inflamasi yang Besar\u00a0<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.nanovest.io/blog\/saham-as\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\/#Perkuat_Mesin_Pertumbuhan_AbbVie\" >Perkuat Mesin Pertumbuhan AbbVie\u00a0<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.nanovest.io/blog\/saham-as\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\/#Investor_Menilai_Potensi_Jangka_Panjang\" >Investor Menilai Potensi Jangka Panjang\u00a0<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Fokus_pada_Pasar_Penyakit_Inflamasi_yang_Besar\"><\/span><b>Fokus pada Pasar Penyakit Inflamasi yang Besar\u00a0<\/b><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Apogee merupakan perusahaan bioteknologi tahap klinis yang saat ini belum memiliki produk komersial. Namun, perusahaan tersebut memiliki sejumlah kandidat terapi untuk penyakit inflamasi dan imunologi yang dinilai menjanjikan.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Aset utama Apogee adalah zumilokibart, kandidat terapi untuk dermatitis atopik atau eksim yang menunjukkan hasil positif dalam uji klinis tahap menengah awal tahun ini. Kabar keberhasilan uji coba tersebut sempat mendorong saham Apogee melonjak hampir 20% pada Maret lalu.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Yang menarik perhatian investor adalah potensi diferensiasi produk tersebut. Data awal menunjukkan terapi ini berpotensi diberikan hanya beberapa kali dalam setahun, jauh lebih jarang dibanding beberapa terapi yang sudah tersedia di pasar saat ini.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Selain dermatitis atopik, Apogee juga mengembangkan kandidat terapi untuk asma dan penyakit paru obstruktif kronis (PPOK), dua pasar dengan kebutuhan pengobatan jangka panjang yang besar.<\/span><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Perkuat_Mesin_Pertumbuhan_AbbVie\"><\/span><b>Perkuat Mesin Pertumbuhan AbbVie\u00a0<\/b><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Bagi AbbVie, akuisisi ini dinilai sejalan dengan strategi memperkuat lini bisnis imunologi yang selama ini menjadi salah satu pilar utama perusahaan.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Portofolio imunologi AbbVie yang mencakup Humira, Skyrizi, dan Rinvoq menghasilkan pendapatan sekitar US$30,4 miliar sepanjang tahun lalu, tumbuh sekitar 14% dibanding tahun sebelumnya. Di tengah meningkatnya persaingan dan berakhirnya masa eksklusivitas sejumlah produk lama, perusahaan membutuhkan sumber pertumbuhan baru untuk menjaga momentum bisnis jangka panjang.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Akuisisi Apogee juga memberi AbbVie akses terhadap kandidat terapi yang masih berada pada tahap pengembangan, sehingga berpotensi memperpanjang pipeline produk perusahaan untuk beberapa tahun ke depan.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Langkah tersebut mencerminkan tren yang lebih luas di industri farmasi, di mana perusahaan besar semakin aktif mengakuisisi perusahaan bioteknologi untuk memperoleh inovasi dan kandidat obat baru daripada mengembangkan semuanya secara internal.<\/span><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Investor_Menilai_Potensi_Jangka_Panjang\"><\/span><b>Investor Menilai Potensi Jangka Panjang\u00a0<\/b><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Meski Apogee belum memiliki produk yang disetujui regulator, minat AbbVie menunjukkan besarnya nilai yang diberikan pasar terhadap aset bioteknologi dengan data klinis yang menjanjikan.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Belum lama ini, Apogee juga berhasil memperoleh komitmen pendanaan hingga US$1,3 miliar dari Blackstone Life Sciences untuk mendukung pengembangan uji klinis tahap lanjut. Dukungan tersebut semakin memperkuat keyakinan pasar terhadap potensi jangka panjang perusahaan.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Bagi investor, potensi akuisisi ini menjadi salah satu contoh bagaimana perusahaan farmasi besar terus mencari peluang pertumbuhan baru melalui inovasi di bidang imunologi dan penyakit inflamasi. Jika transaksi terealisasi, AbbVie akan semakin memperkuat posisinya di salah satu segmen terapi dengan pertumbuhan tercepat dalam industri kesehatan global.<\/span><\/p>\n<hr \/>\n<p><i><span style=\"font-weight: 400;\">Pantau terus perkembangan saham sektor kesehatan, farmasi, dan pasar global melalui aplikasi <\/span><\/i><a href=\"http:\/\/nanovest.io\"><i><span style=\"font-weight: 400;\">Nanovest<\/span><\/i><\/a><i><span style=\"font-weight: 400;\">. Dapatkan juga berbagai insight investasi terbaru setiap hari melalui <\/span><\/i><a href=\"http:\/\/www.nanovest.io/blog\"><i><span style=\"font-weight: 400;\">News &amp; Artikel Tips Nanovest<\/span><\/i><\/a><i><span style=\"font-weight: 400;\"> untuk membantu Anda mengambil keputusan investasi yang lebih terinformasi.<\/span><\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>AbbVie (ABBV) dikabarkan semakin dekat untuk mengakuisisi perusahaan bioteknologi Apogee Therapeutics dalam transaksi senilai sekitar US$10,9 miliar. Jika terealisasi, kesepakatan ini akan menjadi akuisisi terbesar AbbVie sejak pembelian Allergan senilai US$80 miliar pada 2019. Menurut sejumlah laporan media internasional, investor Apogee diperkirakan akan menerima pembayaran tunai dengan premi sekitar 60% dibanding harga penutupan saham perusahaan<\/p>\n","protected":false},"author":35,"featured_media":22779,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[80,39],"tags":[],"class_list":["post-22778","post","type-post","status-publish","format-standard","has-post-thumbnail","category-berita","category-saham-as"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO Pro 5.0.0.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"AbbVie dikabarkan hampir mengakuisisi Apogee Therapeutics senilai US$10,9 miliar. Langkah ini berpotensi memperkuat bisnis imunologi perusahaan di masa depan.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Maretha Putri\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.nanovest.io/blog\/saham-as\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO Pro (AIOSEO) 5.0.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"id_ID\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Blog Nanovest - Artikel dan Berita Kripto, Saham AS, dan Emas\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"AbbVie Perkuat Bisnis Imunologi Lewat Akuisisi Apogee\" \/>\n\t\t<meta property=\"og:description\" content=\"AbbVie dikabarkan hampir mengakuisisi Apogee Therapeutics senilai US$10,9 miliar. Langkah ini berpotensi memperkuat bisnis imunologi perusahaan di masa depan.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.nanovest.io/blog\/saham-as\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/06\/ChatGPT-Image-Jun-22-2026-09_42_08-AM.webp\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/06\/ChatGPT-Image-Jun-22-2026-09_42_08-AM.webp\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-06-22T02:43:20+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-06-22T02:43:20+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/nanovest\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@nanovest_io\" \/>\n\t\t<meta name=\"twitter:title\" content=\"AbbVie Perkuat Bisnis Imunologi Lewat Akuisisi Apogee\" \/>\n\t\t<meta name=\"twitter:description\" content=\"AbbVie dikabarkan hampir mengakuisisi Apogee Therapeutics senilai US$10,9 miliar. Langkah ini berpotensi memperkuat bisnis imunologi perusahaan di masa depan.\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@nanovest_io\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/06\/ChatGPT-Image-Jun-22-2026-09_42_08-AM.webp\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.nanovest.io/blog\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/category\\\/saham-as\\\/#listItem\",\"name\":\"Saham AS\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/category\\\/saham-as\\\/#listItem\",\"position\":2,\"name\":\"Saham AS\",\"item\":\"https:\\\/\\\/www.nanovest.io/blog\\\/category\\\/saham-as\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\\\/#listItem\",\"name\":\"AbbVie Perkuat Bisnis Imunologi Lewat Akuisisi Apogee\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\\\/#listItem\",\"position\":3,\"name\":\"AbbVie Perkuat Bisnis Imunologi Lewat Akuisisi Apogee\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/category\\\/saham-as\\\/#listItem\",\"name\":\"Saham AS\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\\\/#newsarticle\",\"name\":\"AbbVie Perkuat Bisnis Imunologi Lewat Akuisisi Apogee\",\"headline\":\"AbbVie Perkuat Bisnis Imunologi Lewat Akuisisi Apogee\",\"author\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/author\\\/maretha\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/ChatGPT-Image-Jun-22-2026-09_42_08-AM.webp\",\"width\":1536,\"height\":1024,\"caption\":\"Two large puzzle pieces display Abbvie and Apogee logos on a sunlit research campus, with scientists in lab coats at a glass-walled building backdrop at sunrise.\"},\"datePublished\":\"2026-06-22T09:43:20+07:00\",\"dateModified\":\"2026-06-22T09:43:20+07:00\",\"inLanguage\":\"id-ID\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\\\/#webpage\"},\"articleSection\":\"Berita, Saham AS\",\"dateline\":\"Published on Juni 22, 2026.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#organization\",\"name\":\"Nanovest\",\"description\":\"Artikel dan Berita Kripto, Saham AS, dan Emas\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/site-logo-color.png\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\\\/#organizationLogo\",\"width\":250,\"height\":250,\"caption\":\"site-logo-color\"},\"image\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/nanovest\",\"https:\\\/\\\/twitter.com\\\/nanovest_io\",\"https:\\\/\\\/www.instagram.com\\\/nanovest.io\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UC5Y5fD2FApTWMc0c2mlxzIg\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nano-vest\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/author\\\/maretha\\\/#author\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/author\\\/maretha\\\/\",\"name\":\"Maretha Putri\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\\\/#authorImage\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/cropped-ChatGPT-Image-Apr-6-2026-12_10_31-PM-96x96.png\",\"width\":96,\"height\":96,\"caption\":\"Maretha Putri\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\\\/#webpage\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\\\/\",\"name\":\"AbbVie Perkuat Bisnis Imunologi Lewat Akuisisi Apogee\",\"description\":\"AbbVie dikabarkan hampir mengakuisisi Apogee Therapeutics senilai US$10,9 miliar. Langkah ini berpotensi memperkuat bisnis imunologi perusahaan di masa depan.\",\"inLanguage\":\"id-ID\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/author\\\/maretha\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/author\\\/maretha\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/ChatGPT-Image-Jun-22-2026-09_42_08-AM.webp\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\\\/#mainImage\",\"width\":1536,\"height\":1024,\"caption\":\"Two large puzzle pieces display Abbvie and Apogee logos on a sunlit research campus, with scientists in lab coats at a glass-walled building backdrop at sunrise.\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/saham-as\\\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\\\/#mainImage\"},\"datePublished\":\"2026-06-22T09:43:20+07:00\",\"dateModified\":\"2026-06-22T09:43:20+07:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/\",\"name\":\"Nanovest\",\"alternateName\":\"Blog Nanovest\",\"description\":\"Artikel dan Berita Kripto, Saham AS, dan Emas\",\"inLanguage\":\"id-ID\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO Pro -->\r\n\t\t<title>AbbVie Perkuat Bisnis Imunologi Lewat Akuisisi Apogee<\/title>\n\n","aioseo_head_json":{"title":"AbbVie Perkuat Bisnis Imunologi Lewat Akuisisi Apogee","description":"AbbVie dikabarkan hampir mengakuisisi Apogee Therapeutics senilai US$10,9 miliar. Langkah ini berpotensi memperkuat bisnis imunologi perusahaan di masa depan.","canonical_url":"https:\/\/www.nanovest.io/blog\/saham-as\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/www.nanovest.io/blog\/saham-as\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog#listItem","position":1,"name":"Home","item":"https:\/\/www.nanovest.io/blog","nextItem":{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/category\/saham-as\/#listItem","name":"Saham AS"}},{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/category\/saham-as\/#listItem","position":2,"name":"Saham AS","item":"https:\/\/www.nanovest.io/blog\/category\/saham-as\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/saham-as\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\/#listItem","name":"AbbVie Perkuat Bisnis Imunologi Lewat Akuisisi Apogee"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/saham-as\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\/#listItem","position":3,"name":"AbbVie Perkuat Bisnis Imunologi Lewat Akuisisi Apogee","previousItem":{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/category\/saham-as\/#listItem","name":"Saham AS"}}]},{"@type":"NewsArticle","@id":"https:\/\/www.nanovest.io/blog\/saham-as\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\/#newsarticle","name":"AbbVie Perkuat Bisnis Imunologi Lewat Akuisisi Apogee","headline":"AbbVie Perkuat Bisnis Imunologi Lewat Akuisisi Apogee","author":{"@id":"https:\/\/www.nanovest.io/blog\/author\/maretha\/#author"},"publisher":{"@id":"https:\/\/www.nanovest.io/blog\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/06\/ChatGPT-Image-Jun-22-2026-09_42_08-AM.webp","width":1536,"height":1024,"caption":"Two large puzzle pieces display Abbvie and Apogee logos on a sunlit research campus, with scientists in lab coats at a glass-walled building backdrop at sunrise."},"datePublished":"2026-06-22T09:43:20+07:00","dateModified":"2026-06-22T09:43:20+07:00","inLanguage":"id-ID","mainEntityOfPage":{"@id":"https:\/\/www.nanovest.io/blog\/saham-as\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\/#webpage"},"isPartOf":{"@id":"https:\/\/www.nanovest.io/blog\/saham-as\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\/#webpage"},"articleSection":"Berita, Saham AS","dateline":"Published on Juni 22, 2026."},{"@type":"Organization","@id":"https:\/\/www.nanovest.io/blog\/#organization","name":"Nanovest","description":"Artikel dan Berita Kripto, Saham AS, dan Emas","url":"https:\/\/www.nanovest.io/blog\/","logo":{"@type":"ImageObject","url":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2023\/03\/site-logo-color.png","@id":"https:\/\/www.nanovest.io/blog\/saham-as\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\/#organizationLogo","width":250,"height":250,"caption":"site-logo-color"},"image":{"@id":"https:\/\/www.nanovest.io/blog\/saham-as\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/nanovest","https:\/\/twitter.com\/nanovest_io","https:\/\/www.instagram.com\/nanovest.io\/","https:\/\/www.youtube.com\/channel\/UC5Y5fD2FApTWMc0c2mlxzIg","https:\/\/www.linkedin.com\/company\/nano-vest\/"]},{"@type":"Person","@id":"https:\/\/www.nanovest.io/blog\/author\/maretha\/#author","url":"https:\/\/www.nanovest.io/blog\/author\/maretha\/","name":"Maretha Putri","image":{"@type":"ImageObject","@id":"https:\/\/www.nanovest.io/blog\/saham-as\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\/#authorImage","url":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/04\/cropped-ChatGPT-Image-Apr-6-2026-12_10_31-PM-96x96.png","width":96,"height":96,"caption":"Maretha Putri"}},{"@type":"WebPage","@id":"https:\/\/www.nanovest.io/blog\/saham-as\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\/#webpage","url":"https:\/\/www.nanovest.io/blog\/saham-as\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\/","name":"AbbVie Perkuat Bisnis Imunologi Lewat Akuisisi Apogee","description":"AbbVie dikabarkan hampir mengakuisisi Apogee Therapeutics senilai US$10,9 miliar. Langkah ini berpotensi memperkuat bisnis imunologi perusahaan di masa depan.","inLanguage":"id-ID","isPartOf":{"@id":"https:\/\/www.nanovest.io/blog\/#website"},"breadcrumb":{"@id":"https:\/\/www.nanovest.io/blog\/saham-as\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\/#breadcrumblist"},"author":{"@id":"https:\/\/www.nanovest.io/blog\/author\/maretha\/#author"},"creator":{"@id":"https:\/\/www.nanovest.io/blog\/author\/maretha\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/06\/ChatGPT-Image-Jun-22-2026-09_42_08-AM.webp","@id":"https:\/\/www.nanovest.io/blog\/saham-as\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\/#mainImage","width":1536,"height":1024,"caption":"Two large puzzle pieces display Abbvie and Apogee logos on a sunlit research campus, with scientists in lab coats at a glass-walled building backdrop at sunrise."},"primaryImageOfPage":{"@id":"https:\/\/www.nanovest.io/blog\/saham-as\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\/#mainImage"},"datePublished":"2026-06-22T09:43:20+07:00","dateModified":"2026-06-22T09:43:20+07:00"},{"@type":"WebSite","@id":"https:\/\/www.nanovest.io/blog\/#website","url":"https:\/\/www.nanovest.io/blog\/","name":"Nanovest","alternateName":"Blog Nanovest","description":"Artikel dan Berita Kripto, Saham AS, dan Emas","inLanguage":"id-ID","publisher":{"@id":"https:\/\/www.nanovest.io/blog\/#organization"}}]},"og:locale":"id_ID","og:site_name":"Blog Nanovest - Artikel dan Berita Kripto, Saham AS, dan Emas","og:type":"article","og:title":"AbbVie Perkuat Bisnis Imunologi Lewat Akuisisi Apogee","og:description":"AbbVie dikabarkan hampir mengakuisisi Apogee Therapeutics senilai US$10,9 miliar. Langkah ini berpotensi memperkuat bisnis imunologi perusahaan di masa depan.","og:url":"https:\/\/www.nanovest.io/blog\/saham-as\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\/","og:image":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/06\/ChatGPT-Image-Jun-22-2026-09_42_08-AM.webp","og:image:secure_url":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/06\/ChatGPT-Image-Jun-22-2026-09_42_08-AM.webp","og:image:width":1536,"og:image:height":1024,"article:published_time":"2026-06-22T02:43:20+00:00","article:modified_time":"2026-06-22T02:43:20+00:00","article:publisher":"https:\/\/www.facebook.com\/nanovest","twitter:card":"summary_large_image","twitter:site":"@nanovest_io","twitter:title":"AbbVie Perkuat Bisnis Imunologi Lewat Akuisisi Apogee","twitter:description":"AbbVie dikabarkan hampir mengakuisisi Apogee Therapeutics senilai US$10,9 miliar. Langkah ini berpotensi memperkuat bisnis imunologi perusahaan di masa depan.","twitter:creator":"@nanovest_io","twitter:image":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/06\/ChatGPT-Image-Jun-22-2026-09_42_08-AM.webp"},"aioseo_meta_data":{"post_id":"22778","title":"#post_title","description":"AbbVie dikabarkan hampir mengakuisisi Apogee Therapeutics senilai US$10,9 miliar. Langkah ini berpotensi memperkuat bisnis imunologi perusahaan di masa depan.","keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":true,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"NewsArticle","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"seo_analyzer_scan_date":"2026-06-22 02:44:18","breadcrumb_settings":null,"limit_modified_date":false,"reviewed_by":null,"open_ai":null,"ai":{"faqs":[],"keyPoints":[],"schemas":[],"titles":[],"descriptions":[],"socialPosts":{"email":[],"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2026-06-22 02:40:50","updated":"2026-06-22 03:06:19","focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.nanovest.io/blog\" title=\"Home\">Home<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.nanovest.io/blog\/category\/saham-as\/\" title=\"Saham AS\">Saham AS<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\tAbbVie Perkuat Bisnis Imunologi Lewat Akuisisi Apogee\n<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.nanovest.io/blog"},{"label":"Saham AS","link":"https:\/\/www.nanovest.io/blog\/category\/saham-as\/"},{"label":"AbbVie Perkuat Bisnis Imunologi Lewat Akuisisi Apogee","link":"https:\/\/www.nanovest.io/blog\/saham-as\/abbvie-perkuat-bisnis-imunologi-lewat-akuisisi-apogee-22778\/"}],"_links":{"self":[{"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/posts\/22778","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/comments?post=22778"}],"version-history":[{"count":1,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/posts\/22778\/revisions"}],"predecessor-version":[{"id":22780,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/posts\/22778\/revisions\/22780"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/media\/22779"}],"wp:attachment":[{"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/media?parent=22778"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/categories?post=22778"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/tags?post=22778"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}